Antibacterial Activity of Terpene Natural Compounds against Klebsiella pneumoniae: in silico study
Abstract
Klebsiella pneumoniae, a Gram-negative, nonmotile, encapsulated rod-shaped
bacterium has become an emerging nosocomial pathogen that can cause clinical
infectious diseases. Through the years, frequent use and contact with antibiotics in
hospitals have created antibiotic-resistant K. pneumoniae strains, limiting available
treatment options for medical intervention against infections. Many proteins support the
property of antibiotic resistance and one of these proteins found in Klebsiella bacteria is
beta-lactamase SHV-1.
Many terpenes are known to be active against a wide variety of microorganisms,
including gram-positive and gram-negative bacteria and fungi. Toxic effects on
membrane structure and function have been generally used to explain the antimicrobial
action of essential oils and their monoterpenoid components.
Monoterpene indole alkaloids (MIAs) are compounds that are identified from six
genera of the Apocynaceae family. The following genera are Alstonia, Rauvolfia, Kopsia,
Ervatamia, Tabernaemontana, and Rhazya. Traditionally, plant species of this family
have been used for the treatment of fever, malaria, gastrointestinal ailments, diabetes, and
pain. There are many terpenes natural compounds (>400 compounds). Thus, finding the
terpene compounds that strongly interact with the targeted protein in K. pneumoniae
would serve as a potential strategy to find the most potent compounds.
The recent study examined the potential interactions between beta-lactamase (bla
SHV-1), a protein that supports antibiotic resistance in Klebsiella, and MIAs from six
genera of plants in the Apocynaceae family. The MIAs were used as ligands in this study.
The PyRx program for molecular docking and other computer programs were used to
assess the effectiveness of MIAs as inhibitors (PyMOL, LigPlot+, Discovery Studio,
Notepad, Gimp 2.10).
In this study, the initial molecular docking investigation identified several MIAs
with potential as inhibitors. Paucidisine, (-)-19-Oxoisoeburnamine, and paucidactine A
demonstrated the most promise. Ligand-protein interactions, such as hydrogen bonds and
hydrophobic interactions, were also analyzed to determine the best terpenes. The most
effective terpenes showed a higher percentage of similarity when compared to native
ligands.
It is important to note that these findings are based on an in silico study and require
in vitro confirmation before being considered for future drug design. Overall, this study
takes a significant step toward discovering alternative treatment options for antibiotic-resistant Klebsiella infections. By exploring the potential of MIAs as inhibitors, this
research offers a promising avenue for combating antibiotic resistance and improving
patient outcomes.